Kiniksa Pharmaceuticals, Ltd.

Q2 2025 13F Holders

Symbol
KNSA
CUSIP
G52694109
Type
Equity
Class
ORD SHS CL A
Num filings
197
Total reported value, excl. options
$1.13 B
Manager Report Date Value ($000) Shares Option Type